Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6938
Gene Symbol: TCF12
TCF12
0.010 Biomarker disease BEFREE Furthermore, SNHG1/miR-556-5p/TCF12 axis promoted cell proliferation and suppressed cell apoptosis in meningioma via activating the Wnt signaling pathway. 31692066 2020
Entrez Id: 23642
Gene Symbol: SNHG1
SNHG1
0.010 AlteredExpression disease BEFREE In this work, it was discovered that SNHG1 was overexpressed in meningioma cell lines. 31692066 2020
Entrez Id: 2108
Gene Symbol: ETFA
ETFA
0.010 Biomarker disease BEFREE Each meningioma had foci of limited meningothelial amongst extensive myxoid histology with Alcian-blue-staining stroma and EMA-immunoreactive cells. 31347490 2020
Entrez Id: 3956
Gene Symbol: LGALS1
LGALS1
0.010 Biomarker disease BEFREE In this study the potential of Farnesol in the treatment of optic nerve meningioma was evaluated by examining its antiproliferative effects against the HBL-52 cells. 31786891 2020
Entrez Id: 64115
Gene Symbol: VSIR
VSIR
0.010 Biomarker disease BEFREE Expression profiles of immune checkpoint proteins (PD-L1, B7-H3, LAG3, PD-1 and VISTA) were explored by immunohistochemistry (IHC) in a meningioma test-cohort (n = 8). 31629137 2020
Entrez Id: 1844
Gene Symbol: DUSP2
DUSP2
0.010 Biomarker disease BEFREE Additionally, procaspase-3 expressing glioma and meningioma cell lines were sensitive to the apoptotic effects of PAC-1 at biologically relevant exposures achievable in cancer patients. 30859090 2019
Entrez Id: 3832
Gene Symbol: KIF11
KIF11
0.010 Biomarker disease BEFREE Identification of KIF11 As a Novel Target in Meningioma. 30991738 2019
Entrez Id: 1316
Gene Symbol: KLF6
KLF6
0.010 Biomarker disease BEFREE Additionally, procaspase-3 expressing glioma and meningioma cell lines were sensitive to the apoptotic effects of PAC-1 at biologically relevant exposures achievable in cancer patients. 30859090 2019
Entrez Id: 1493
Gene Symbol: CTLA4
CTLA4
0.010 Biomarker disease BEFREE Here, we report for the first time the expression profiles of immune checkpoint proteins PD-L2, B7-H3 and CTLA-4 in meningioma and their association to common gene mutations. 30546952 2019
Entrez Id: 7442
Gene Symbol: TRPV1
TRPV1
0.010 AlteredExpression disease BEFREE To investigate the expression profile of TRPV1-4 channels in meningiomas and compare with TRPV1-4 channel expression in leptomeninges, we used immunohistochemistry in formalin-fixed, paraffin-embedded semi-serial tissue sections from 175 meningiomas with different grades and histological subtypes, and normal brain or meningioma specimens that contained leptomeninges. 31119368 2019
Entrez Id: 55706
Gene Symbol: NDC1
NDC1
0.010 GeneticVariation disease BEFREE The multivariate analysis in JR-NET2 showed that embolization for tumors other than meningioma was the only significant risk factor for complication (odds ratio [OR], 3.88; 95% confidence interval [CI], 1.13-12.10; p = 0.032), and that in JR-NET3 revealed that embolization for feeders other than external carotid artery (ECA) (OR, 3.56; 95% CI, 2.03-6.25; p < 0.001) and use of liquid materials (OR, 2.65; 95% CI, 1.50-4.68; p < 0.001) were significant risks for complications. 31172282 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 AlteredExpression disease BEFREE TNF-α and IL-1β expressions were significantly higher in the meningioma and glioma group in comparison to control group. 31653130 2019
Entrez Id: 4763
Gene Symbol: NF1
NF1
0.010 GeneticVariation disease BEFREE Mutations in the <i>neurofibromin 2</i> (<i>NF2</i>) gene were among the first genetic alterations implicated in meningioma tumorigenesis, based on analysis of neurofibromatosis type 2 (NF2) patients who not only develop vestibular schwannomas but later have a high incidence of meningiomas. 31652973 2019
Entrez Id: 4211
Gene Symbol: MEIS1
MEIS1
0.010 Biomarker disease BEFREE We evaluated the function of Meningioma 1 (MN1), a cofactor of HOXA9 and MEIS1, in human and murine MLL-rearranged leukemia by CRISPR-Cas9 mediated deletion of MN1. 31413090 2019
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
0.010 Biomarker disease BEFREE Furthermore, no statistically significant joint effect of aromatase inhibitors and tamoxifen on the occurrence of meningioma among breast cancer patients was seen. 31249531 2019
Entrez Id: 91754
Gene Symbol: NEK9
NEK9
0.010 Biomarker disease BEFREE Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism. 30594554 2019
Entrez Id: 3230
Gene Symbol: HOXD@
HOXD@
0.010 Biomarker disease BEFREE This analysis also revealed a super enhancer near the HOXD gene cluster in this MC, which, together with general upregulation of HOX genes in the malignant MC, indicates a role of HOX genes in meningioma aggressiveness. 31069492 2019
Entrez Id: 65009
Gene Symbol: NDRG4
NDRG4
0.010 Biomarker disease BEFREE Moreover, NDRG1, NDRG2, and NDRG4 are all involved in cancers of the nervous system, such as glioma, neuroblastoma, or meningioma. 31485792 2019
Entrez Id: 1718
Gene Symbol: DHCR24
DHCR24
0.010 Biomarker disease BEFREE Furthermore, there was a moderate positive correlation between Ktrans and time to progression, which approached, but did not reach, statistical significance (r = 0.48, p = 0.05).CONCLUSIONSThis study demonstrates a potential role for DCE MRI in the preoperative characterization and stratification of meningiomas, laying the foundation for future prospective studies incorporating DCE as a biomarker in meningioma diagnosis and treatment planning. 31153141 2019
Entrez Id: 23554
Gene Symbol: TSPAN12
TSPAN12
0.010 Biomarker disease BEFREE The multivariate analysis in JR-NET2 showed that embolization for tumors other than meningioma was the only significant risk factor for complication (odds ratio [OR], 3.88; 95% confidence interval [CI], 1.13-12.10; p = 0.032), and that in JR-NET3 revealed that embolization for feeders other than external carotid artery (ECA) (OR, 3.56; 95% CI, 2.03-6.25; p < 0.001) and use of liquid materials (OR, 2.65; 95% CI, 1.50-4.68; p < 0.001) were significant risks for complications. 31172282 2019
Entrez Id: 374
Gene Symbol: AREG
AREG
0.010 AlteredExpression disease BEFREE For validation studies, we utilized an independent set of meningioma tumor tissue samples (Grade I, <i>n</i> = 20; Grade II, <i>n</i> = 10; Grade III, <i>n</i> = 6), and found that the expressions of amphiregulin and Caspase3 are significantly increased in all grades of meningiomas either at the transcriptional or protein level, respectively. 31649887 2019
Entrez Id: 23336
Gene Symbol: SYNM
SYNM
0.010 Biomarker disease BEFREE Task-evoked changes in functional connectivity strength (defined as the mean of the absolute values of all connections) and in functional connectivity patterns within and between the FPN and DMN did not differ significantly across meningioma and fast (HGG) and slowly growing glioma (LGG) patients. 31456158 2019
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.010 GeneticVariation disease BEFREE Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort. 30137467 2019
Entrez Id: 6624
Gene Symbol: FSCN1
FSCN1
0.010 AlteredExpression disease BEFREE We aimed to investigate the expression of E-cadherin and Fascin in a large number of meningioma specimens and determine if clinical and prognostic significance existsMETHODS: One hundred and thirty-four spinal and intracranial meningioma samples were collected. 31322546 2019
Entrez Id: 8549
Gene Symbol: LGR5
LGR5
0.010 Biomarker disease BEFREE Taken together, LGR5 and its downstream signaling play critical roles in neuroblastoma and brain tumors such as meningioma and pituitary adenoma. 31698554 2019